Corinna Klein, PhD


Group Leader, Molecular Histology and Project Management AbbVie, Ludwigshafen, Germany

Education and Training: 

  • 2006-2008: Presidential Postdoctoral Fellow, Neuroscience Discovery, Novartis Institutes of Biomedical Research, Novartis, Basel, Switzerland
  • 2002-2006: Postdoctoral Fellow, Gordon Fishell Lab, Skirball Institute, NYU School of Medicine, NY
  • 2001: Ph.D. in Neurobiology, Ruprecht-Karls-University Heidelberg, Germany
  • 1997: Diploma in Biology, Ruprecht Karls Universtiy Heidelberg, Germany

Current or Past Study:
As a neuroscientist by training my research is driven by the aim to elucidate the underlying mechanisms of neurological disorders such as Multiple Sclerosis and Huntington´s Disease and to understand if mechanisms employed during development of an organism can be reapplied to restore disease-related deficits. Currently, my lab is working on elucidating and ameliorating neural deficits by manipulating novel molecular targets and signaling pathways in animal models of neurodegenerative diseases such as Alzheimer and Huntington ’s disease, as well as in Multiple Sclerosis and psychiatric disorders such as Schizophrenia.